Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects

被引:47
作者
Catalano, Giovanna [1 ,2 ]
Duchene, Emilie [1 ,2 ]
Julia, Zelie [1 ,2 ]
Le Goff, Wilfried [1 ,2 ]
Bruckert, Eric [3 ]
Chapman, M. John [1 ,2 ]
Guerin, Maryse [1 ,2 ]
机构
[1] Inst Natl Sante & Rech Med, UMR Dyslipoproteinemia & Atherosclerosis S551, Paris, France
[2] Univ Paris 06, Unite Mixte Rech S551, Paris, France
[3] Hop La Pitie Salpetriere, Hop Assitance Publ Hop Paris, Dept Endocrinol, Paris, France
关键词
ATP binding cassette G1; scavenger receptor class B type I; high-density-lipoprotein;
D O I
10.1194/jlr.M700510-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We evaluated the impact of gender differences in both the quantitative and qualitative features of HDL subspecies on cellular free cholesterol efflux through the scavenger receptor class B type I (SR-BI), ABCA1, and ABCG1 pathways. For that purpose, healthy subjects (30 men and 26 women) matched for age, body mass index, triglyceride, apolipoprotein A-1, and high density lipoprotein-cholesterol (HDL-C) levels were recruited. We observed a significant increase (+14%; P < 0.03) in the capacity of whole sera from women to mediate cellular free cholesterol efflux via the SR-BI-dependent pathway compared with sera from men. Such enhanced efflux capacity resulted from a significant increase in plasma levels of large cholesteryl ester-rich HDL2 particles (+20%; P < 0.04) as well as from an enhanced capacity (+14%; P < 0.03) of these particles to mediate cellular free cholesterol efflux via SR-BI. By contrast, plasma from men displayed an enhanced free cholesterol efflux capacity (+31%; P < 0.001) via the ABCA1 transporter pathway compared with that from women, which resulted from a 2.4-fold increase in the plasma level of prep particles (P < 0.008). Moreover, in women, SR-BI-mediated cellular free cholesterol efflux was significantly correlated with plasma HDL-C (r = 0.72, P < 0.0001), whereas this relationship was not observed in men. In conclusion, HDL-C level may not represent the absolute indicator of the efficiency of the initial step of the reverse cholesterol transport.
引用
收藏
页码:635 / 643
页数:9
相关论文
共 38 条
[1]   The roles of different pathways in the release of cholesterol from macrophages [J].
Adorni, Maria Pia ;
Zimetti, Francesca ;
Billheimer, Jeffrey T. ;
Wang, Nan ;
Rader, Daniel J. ;
Phillips, Michael C. ;
Rothblat, George H. .
JOURNAL OF LIPID RESEARCH, 2007, 48 (11) :2453-2462
[2]  
APPLEBAUMBOWDEN D, 1989, J LIPID RES, V30, P1895
[3]   Estrogens and atherosclerosis [J].
Arnal, JF ;
Gourdy, P ;
Elhage, R ;
Garmy-Susini, B ;
Delmas, E ;
Brouchet, L ;
Castano, C ;
Barreira, Y ;
Couloumiers, JC ;
Prats, H ;
Prats, AC ;
Bayard, F .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (02) :113-117
[4]   HDL in atherosclerosis: actor or bystander? [J].
Asztalos, BF ;
Schaefer, EJ .
ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (01) :21-29
[5]   HUMAN HDL CHOLESTEROL LEVELS ARE DETERMINED BY APOA-I FRACTIONAL CATABOLIC RATE, WHICH CORRELATES INVERSELY WITH ESTIMATES OF HDL PARTICLE-SIZE [J].
BRINTON, EA ;
EISENBERG, S ;
BRESLOW, JL .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05) :707-720
[6]   Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL [J].
Chancharme, L ;
Thérond, P ;
Nigon, F ;
Lepage, S ;
Couturier, M ;
Chapman, MJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :810-820
[7]   Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid - a position paper developed by the European Consensus Panel on HDL-C [J].
Chapman, MJ ;
Assmann, G ;
Fruchart, JC ;
Shepherd, J ;
Sirtori, C .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (08) :1253-1268
[8]  
CHAPMAN MJ, 1981, J LIPID RES, V22, P339
[9]   Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification [J].
Colhoun, HM ;
Scheek, LM ;
Rubens, MB ;
Van Gent, T ;
Underwood, SR ;
Fuller, JH ;
Van Tol, A .
DIABETES, 2001, 50 (03) :652-659
[10]  
de la Llera-Moya M, 1999, J LIPID RES, V40, P575